108 related articles for article (PubMed ID: 12755548)
1. Slow spin exchange explains the effects of diuresis on gadolinium enhancement in MR imaging in the kidney, not in other organs.
den Boer JA; de Priester JA; van Engelshoven JM; Hasman A
Acad Radiol; 2003 May; 10(5):567-8; author reply 568-9. PubMed ID: 12755548
[No Abstract] [Full Text] [Related]
2. Initial results of the effects of diuresis on gadolinium enhancement in MR imaging of the abdomen.
Katzberg RW; Ivanovic M; Buonocore MH; Brock JM; Ryan JM; Whang K
Acad Radiol; 2002 Aug; 9(8):886-94. PubMed ID: 12186436
[TBL] [Abstract][Full Text] [Related]
3. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
Shuter B; Tofts PS; Wang SC; Pope JM
Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
[TBL] [Abstract][Full Text] [Related]
4. Overhauser-enhanced MR imaging (OMRI).
Golman K; Leunbach I; Ardenkjaer-Larsen JH; Ehnholm GJ; Wistrand LG; Petersson JS; Järvi A; Vahasalo S
Acta Radiol; 1998 Jan; 39(1):10-7. PubMed ID: 9498861
[TBL] [Abstract][Full Text] [Related]
5. Yb-DTPA, a novel contrast agent in magnetic resonance imaging: application to rat kidney.
Sarkar SK; Rycyna RE; Lenkinski RE; Solleveld HA; Kinter LB
Magn Reson Med; 1991 Feb; 17(2):328-35. PubMed ID: 2062207
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
Jia J; Puls D; Oswald S; Jedlitschky G; Kühn JP; Weitschies W; Hosten N; Siegmund W; Keiser M
Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
[TBL] [Abstract][Full Text] [Related]
8. Modeling (1H) exchange: an estimate of the error introduced in MRI by assuming the fast exchange limit in bolus tracking.
Moran GR; Prato FS
Magn Reson Med; 2004 Apr; 51(4):816-27. PubMed ID: 15065256
[TBL] [Abstract][Full Text] [Related]
9. Effects of myocardial water exchange on T1 enhancement during bolus administration of MR contrast agents.
Judd RM; Atalay MK; Rottman GA; Zerhouni EA
Magn Reson Med; 1995 Feb; 33(2):215-23. PubMed ID: 7707912
[TBL] [Abstract][Full Text] [Related]
10. T2 exchange agents: a new class of paramagnetic MRI contrast agent that shortens water T2 by chemical exchange rather than relaxation.
Soesbe TC; Merritt ME; Green KN; Rojas-Quijano FA; Sherry AD
Magn Reson Med; 2011 Dec; 66(6):1697-703. PubMed ID: 21608031
[TBL] [Abstract][Full Text] [Related]
11. Redox-sensitive contrast agents for MRI based on reversible binding of thiols to serum albumin.
Raghunand N; Jagadish B; Trouard TP; Galons JP; Gillies RJ; Mash EA
Magn Reson Med; 2006 Jun; 55(6):1272-80. PubMed ID: 16700014
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
[TBL] [Abstract][Full Text] [Related]
13. [Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA].
Zangos S; Hammerstingl R; Mack MG; Straub R; Engelmann K; Eichler K; Balzer T; Vogl TJ
Rofo; 2001 Nov; 173(11):1034-40. PubMed ID: 11704914
[TBL] [Abstract][Full Text] [Related]
14. Cortical, medullary, and pelvocaliceal MR renography with and without diuretic modification.
Katzberg RW; Ivanovic M; Buonocore MH; Brock JM; Ryan JM
Acad Radiol; 2003 Jul; 10(7):725-38. PubMed ID: 12862282
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
[TBL] [Abstract][Full Text] [Related]
16. Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
Talakic E; Steiner J; Kalmar P; Lutfi A; Quehenberger F; Reiter U; Fuchsjäger M; Schöllnast H
Eur J Radiol; 2014 Apr; 83(4):607-11. PubMed ID: 24380639
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer.
Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW
Magn Reson Med; 1994 Nov; 32(5):622-8. PubMed ID: 7808263
[TBL] [Abstract][Full Text] [Related]
18. Furosemide increases water content in renal tissue.
Pedersen M; Vajda Z; Stødkilde-Jørgensen H; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2007 May; 292(5):F1645-51. PubMed ID: 17264309
[TBL] [Abstract][Full Text] [Related]
19. The influence of furosemide on free water clearance.
Romano G; Bortolotti N; Falleti E; Favret G; Gonano F; Bartoli GE
Panminerva Med; 1999 Jun; 41(2):103-8. PubMed ID: 10479906
[TBL] [Abstract][Full Text] [Related]
20. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
